Όλο το DSpace

Πλοήγηση ανά Θέμα "PHASE-II TRIAL"

Αποτελέσματα 1-3 από 3

    • Antiangiogenic strategies in hepatocellular carcinoma: current status 

      Zacharoulis, D.; Hatzitheofilou, C.; Athanasiou, E.; Zacharoulis, S. (2005)
      Hepatocellular carcinoma is a leading cause of cancer death worldwide in both adult and pediatric patients. Despite many options, no ideal treatment exists for this highly malignant tumor, and management strategies have ...

    • Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells 

      Tsapakidis, K.; Vlachostergios, P. J.; Voutsadakis, I. A.; Befani, C. D.; Patrikidou, A.; Hatzidaki, E.; Daliani, D. D.; Moutzouris, G.; Liakos, P.; Papandreou, C. N. (2012)
      Objectives: Neuropeptides are important signal initiators in advanced prostate cancer, partially acting through activation of nuclear factor kappa B. Central to nuclear factor kappa B regulation is the ubiquitin-proteasome ...

    • Botulinum neurotoxin A for benign prostatic hyperplasia 

      Oeconomou, A.; Madersbacher, H. (2010)
      Purpose of review The injection of botulinum neurotoxin A (BoNT-A) into the prostate represents an alternative, minimal invasive treatment for lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH), ...